Português

GARDP welcomes the G20 Ministerial Declaration on Climate Change, Health and Equity and One Health, which includes recommendations on research and development together with sustained and reliable supply of antimicrobials, especially for low- and middle-income countries.

The declaration was adopted on 31 October 2024 at the G20 Health Ministerial Meeting in Rio de Janeiro.

GARDP congratulates the Government of Brazil for its G20 Presidency and for hosting a productive meeting which brought together governments, inter-governmental organizations and health organizations, including GARDP.

We also applaud member states for adopting the separate Rio de Janeiro Declaration of the G20 Health Ministers, which reaffirmed their commitment to addressing antimicrobial resistance (AMR). The declaration outlines the establishment of the ‘Global Coalition for Local and Regional Production, Innovation and Equitable Access’ – an important initiative proposed by the Government of Brazil. We hope the Coalition will respond to key needs around research and development as well as innovation and equitable access to new and existing antibiotics to treat drug-resistant infections.

GARDP looks forward to the fourth Global High-Level Ministerial Conference on AMR in Jeddah in November 2024, which will be hosted by Saudi Arabia. We share the expectation by G20 Health Ministers that the meeting will ‘pave an ambitious way to tackle the major global threat of AMR’ over the years ahead and put into action the commitments agreed to at the UN High-Level Meeting on AMR in September 2024. GARDP will be participating in the meeting and is keen to play its part in offering concrete solutions to the challenges of AMR.

During Brazil’s G20 presidency, GARDP has taken part in discussions on climate change, One Health, and AMR. In June 2024, we co-hosted a session, together with the Pan American Health Organization (PAHO), entitled ‘Access to Medicines: A Push Towards Optimizing the AMR Response’ in Salvador, Brazil. It was an excellent opportunity to engage with global health leaders to advocate for access to antibiotics.

We appreciate the G20’s recognition of the key role GARDP is playing and look forward to working with countries and partners to counter AMR and save lives. We are keen to support South Africa when it assumes the Presidency of the G20 in 2025 through our work in research & development and expanding access to antibiotic treatments.